Evidence map›Paper›PMID 40344310›Full record

ArticleUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2025

Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns.

J Miranda, L Benitez, S Macías-Redondo, C Paules, A Gomez-Gomez, A Basso, F Crovetto, L Youssef, O J Pozo, J Schoorlemmer and 2 more

Abstract read
In one paragraph

Article in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

J Miranda *BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.ORCID 0000-0003-0372-8374
L Benitez *BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
S Macías-RedondoInstituto Aragonés de Ciencias de la Salud (IACS) and Placental Pathophysiology & Fetal Programming Research Group, Zaragoza, Spain.
C PaulesBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
A Gomez-GomezApplied Metabolomics Research Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
A BassoBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
F CrovettoBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
L YoussefBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
O J PozoApplied Metabolomics Research Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
J SchoorlemmerInstituto Aragonés de Ciencias de la Salud (IACS) and Placental Pathophysiology & Fetal Programming Research Group, Zaragoza, Spain.
F CrispiBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.
E GratacósBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), University of Barcelona, Barcelona, Spain.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca grant nº 1531Bolivar Gana con CienciaCerebra Foundation for the Brain Injured ChildErasmus + Programme of the European Union Framework Agreement number: 2013-0040Fundació Dexeus MujerFundació Jesús Serra of the Grup Catalana OccidentFundació Mutua MadrileñaInstituto de Salud Carlos III CM16/00142Instituto de Salud Carlos III CM21/00058Instituto de Salud Carlos III INT21/00027Instituto de Salud Carlos III PI14/00226Instituto de Salud Carlos III PI16/00861Instituto de Salud Carlos III PI17/00675Instituto de Salud Carlos III PI18/00073Instituto de Salud Carlos III PI20/00246Instituto de Salud Carlos III PI22/00684la Caixa" Foundation LCF/PR/GN14/10270005Una manera de hacer Europa, Construyen Europa desde Aragón B87 B05_17D B46_20R
6 · The paper itself

Abstract

objectivePrevious research has identified an association between maternal stress, fetal growth and the expression of glucocorticoid-related genes in the placenta, particularly 11-beta hydroxysteroid dehydrogenase-2 (HSD11β2). However, to date, no studies have simultaneously explored the relationships between maternal stress, placental expression and methylation of HSD11β2, and fetal cortisol metabolites according to fetal growth. The aim of the present study was to evaluate the association between perceived antenatal maternal stress, the expression and methylation of the placental HSD11β2 gene, fetal cortisol metabolites in amniotic fluid and birth weight.

methodsThis nested case-control study, which was part of a large prospective cohort study, was conducted at two maternofetal medicine units in Barcelona, Spain (BCNatal: Hospitals Clinic and Sant Joan de Déu). We enrolled singleton pregnancies and classified neonates as small-for-gestational age (SGA) if their birth weight was below the 10

resultsMedian maternal perceived stress (PSS, 23 (interquartile range (IQR), 17-28) vs 20 (IQR, 15-26); P < 0.001) and median anxiety state (STAI-state, 19.0 (IQR, 14.0-29.0) vs 16.0 (IQR, 11.0-24.0); P < 0.001) scores were significantly higher in the SGA group compared with the control group. SGA cases showed lower median placental HSD11β2 RNA expression (Δ Ct, 50.5 (IQR, 21.6-106.0) vs 92.7 (IQR, 62.3-118.0); P = 0.013) with similar DNA methylation levels (mean ± SD, 10.7 ± 3.0% vs 11.0 ± 2.8%; P = 0.648) compared with AGA controls. Analysis of amniotic fluid revealed altered cortisol metabolism in SGA fetuses, with increased median 5α-tetrahydrocortisol concentration (SGA, 0.09% (IQR, 0.06-0.15%) vs controls, 0.07% (IQR, 0.05-0.11%); P = 0.020) and activity of its related enzyme (5α-reductase activity in SGA, 0.19% (IQR, 0.14-0.31%) vs controls, 0.17% (IQR, 0.12-0.22%); P = 0.007), together with a decrease in median 6-hydroxycortisol concentration (SGA, 0.09% (IQR, 0.06-0.11%) vs controls, 0.11% (IQR, 0.08-0.12%); P < 0.001) and activity of its related enzyme (CYP3A7 activity in SGA, 0.19% (IQR, 0.11-0.25%) vs controls, 0.24% (IQR, 0.17-0.33%); P < 0.001).

conclusionsSGA pregnancy is associated with high perceived maternal stress and dysregulated fetoplacental cortisol metabolism. These results deepen our understanding of the pathophysiology of SGA and highlight the potential benefit of intervention to mitigate maternal stress. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 2HydrocortisoneInfant, Small for Gestational AgePlacentaPregnancy ComplicationsStress, PsychologicalAdultAmniotic FluidBirth WeightCase-Control StudiesDNA MethylationFemaleFetal DevelopmentHumansInfant, NewbornPregnancy11-beta-Hydroxysteroid Dehydrogenase Type 2HSD11B2 protein, humanHydrocortisonedevelopmental programmingepigeneticsfetal cortisol metabolismfetal growthmaternal anxietymaternal stressplacental gene expressionsmall‐for‐gestational agesteroid axis

Identifiers

PMID40344310
PMCPMC12127719

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.